Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.20p
   
  • Change Today:
      0.007p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 18,500
  • Market Cap: £4.36m

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
11-Sep-18 Northland Capital Partners Buy 15.75p - 113.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.20p
Change Today 0.007p
% Change -3.30 %
52 Week High 1.22
52 Week Low 0.20
Volume 18,500
Shares Issued 2,148.96m
Market Cap £4.36m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average
90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average
Price Trend
86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average
72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
11:00 18,500 @ 0.22p
11:00 18,500 @ 0.22p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page